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Introduction 
The Behavioral Health and Performance (BHP) Element is one of the six elements in the NASA Human 
Research Program (HRP) and is responsible for managing four of the identified and named risks to human 
health and performance from human space exploration: a) Risk of Behavioral Conditions (Behavioral 
Medicine [BMed]), b) Risk of Psychiatric Disorders (BMed), c) Risk of Performance Decrements due to 
inadequate Cooperation, Coordination, Communication and Psychological Adaptation within a Team 
(Team), and d) Risk of Performance Errors due to Sleep Loss, Circadian De-synchronization, Fatigue and 
Work Overload (Sleep). 
Each risk is reviewed by a NASA HRP Standing Review Panel (SRP), and recently the Behavioral 
Medicine Risk of Psychiatric Disorders was reviewed. The aim of this report is to address one of the 
recommendations made by that panel, specifically the recommendation that the ―literature on asthenia 
should be evaluated (possibly as a psychological or psychosomatic/psycho-physiological analogue of 
chronic fatigue syndrome)‖ (SRP p. 4), in addition to General Recommendation 4, which states that ―all 
reviews must include non-English language materials as well as materials appearing in conferences 
reports, books, and other non-refereed journal outlets‖ (SRP p. 2). 
This task was identified in the broader context of the following recommendations:  
 The SRP recommends combining BMed2 and BMed3, and revising the gap as 
follows: What are the optimal methods to predict, detect, and assess adverse mood 
and other mental states (which may negatively affect performance) during and after 
exploration missions?  
 The list of current tasks focuses exclusively on depression. There is no rationale for 
this limited perspective; there are many other negative states (i.e., irritability, fugue 
states, psychosomatic symptoms, anxiety) that occur in analog environments and 
have occurred in space flight.  
 In the SRP’s judgment, it is unrealistic to expect the biomarkers for depression to 
be found in one research task; i.e., to be able to predict, diagnose, or measure 
depression using neuroimaging methods.  
 An alternative approach would be to focus on the prediction of aversive conditions 
that involve affect, cognition, or behavior, based on findings in the literature on 
elite performers. This somewhat broader goal would refocus the effort on 
identifying affective, cognitive, and behavioral factors that are ―early‖ warning 
signs of deterioration of performance. Moreover, these factors may not neatly fit 
into the categories that are described in the Diagnostic and Statistical Manual for 
Psychiatric Diagnoses. One of these factors is asthenia, which should be evaluated 
(possibly as a psychological or psychosomatic analogue of chronic fatigue 
syndrome), and another is General Recommendation 4. 
This literature review on asthenia will be cognizant of the broader context above, particularly with 
reference to General Recommendation 4 (see above). According to the international literature 
(Aleksandrovskiy 1996, Carter et al. 2005, Carpenter 1997, Chaikin 1985, Gushin et al. 1998, Harris 
1996, Holland & Curtis 1999, Kanas & Manzey 2003, Myasnikov & Zamaledinov 1996, Sipes & Vander 
Ark 2005) and anecdotal references (Burrough 1998, Flynn 2005, Freeman 2000, Harris 1996, Lebedev 
1988), evidence exists that astronauts and cosmonauts have developed and suffered psychological 
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problems such as anxiety, depression, and asthenia during long-duration space flight missions, putting 
themselves and the mission at greater risk. 
One disorder included in this evidence base of literature is asthenia, often described as experiencing 
weakness, with an increased tendency to have fatigue, irritability, and disorder of attention and memory. 
It has been seen by Russian medical personnel (flight surgeons and psychologists) in cosmonauts after 4 
months in space (Grigoriev et al. 1996, Myasnikov & Zamaletdinov 1996). Russian medical personnel 
believe that asthenia is one of the greatest risks that will affect crews’ optimal psychological functioning. 
Observing and determining whether astronauts and/or cosmonauts present asthenia symptoms or signs of 
asthenia during a space flight mission are crucial because asthenia can affect the crew members’ health 
and performance, and mission goals.  
Psychiatrists and psychologists around the world use many classification systems to diagnose psychiatric 
and psychological symptoms, signs, and diseases; however, countries can use their own unique diagnostic 
systems. For example, China uses the Chinese Classification of Mental Disorders (CCMD) and Cuba uses 
the Cuban Glossary of Psychiatry (CGP), which is a general framework taken from the Latin American 
culture. Another system used in Latin American countries is the Latin American Guide for Psychiatric 
Diagnosis (GLADP). On the other hand, the U.S. primarily uses the Diagnostic and Statistical Manual of 
Mental Disorders (DSM), and the World Health Organization and some European and Asian countries 
(including Germany, Switzerland, France, and Russia) use the International Statistical Classification of 
Disease (ICD). According to Shu (1998), ―In general, different classification systems are almost all the 
same in common psychiatric diagnosis and therefore share a high consistency.‖ However, the small 
differences between diagnostic systems have created debate about whether certain diagnosis 
classifications exist in certain countries. Additionally, it should be acknowledged that ―in psychiatric 
practice, symptoms, recognition, disease construction, and taxonomic strategy are reflective and 
constrained by the cultural norms and values as well as the political and economic organizations of the 
society in which they are embedded‖ (Lee 1996) . 
Sadock and Sadock (2005) suggest that ―when considering the different classification systems that exist 
and their cultural influences, there are many reasons why mental health professionals should care about 
the way in which mental disorders are defined. Firstly, the definition of mental disorders guides 
distinguishing pathology from what is normal. Consequently, the definition of mental disorders can 
influence estimates of the prevalence of psychiatric disorders in the community, which, in turn, influences 
the allocation of public health expenditures. Secondly, the definition of mental disorder can affect which 
behavioral, cognitive, and emotional perturbations are included in the classification, and the inclusion and 
exclusion of specific disorders from the DSM have been the source of criticism and controversy.‖ 
Asthenia (or neurasthenia) is one of those diagnoses that have created controversy around the world. The 
diagnosis of asthenia (or neurasthenia) is recognized by the World Health Organization in the ICD-10, but 
it is not recognized by the DSM-IV-TR (APA 2000). The DSM-IV-TR is the principal resource for 
NASA to diagnose psychiatric disorders (McPhee & Charles 2009, Slack et al. 2009). The fact that the 
DSM does not recognize asthenia as a diagnosable problem has caused international debate, especially in 
the area of space psychology. Russia and the United States. argue about whether cosmonauts and 
astronauts develop asthenia in space, and most importantly, they argue about whether we can prevent and 
treat asthenia during a long-duration mission. In addition, it is important to note that the DSM refers to 
neurasthenia as ―a condition characterized by physical and mental fatigue, dizziness, headaches, other 
pains, concentration difficulties, sleep disturbance and memory loss‖ (APA 2000). It is described in an 
appendix called ―Glossary of Cultural-Bound Syndromes,‖ where it is listed as shenjing shuairuo, 
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referring in particular to the Chinese culture and not the U.S. culture (APA 2000, Hickie et al. 1997, Yew 
Schwartz 2002).
 1
  
From a multicultural perspective, there may be cause for concern that U.S. doctors’ procedure for 
diagnosing disorders (that is, utilizing the DSM-IV) does not incorporate asthenia as a diagnosable 
psychiatric disorder. Indeed, ―if our diagnostic systems do not readily match the symptom profiles 
presented, practitioners will continue to under-diagnose psychological disorders‖ (Kessler et al. 1994, 
Mason & Wilkinson 1996, Üstun & Sartorius 1995), which would have a strong impact on the 
international sharing of understanding and knowledge about astronauts’ and cosmonauts’ space flight 
experiences. It could also affect both appropriate training of the crew members and prescribed treatment 
based on observed symptoms. In addition, future missions will include multiple cultures, and this will 
necessitate evaluation of the mental status of an international space crew according to multiple diagnostic 
systems. As missions increase in duration and crews increase in diversity of national origin, these 
characteristics will likely create ―cultural frictions in areas of leadership style, crew communication, pre-
flight training, identification of in-flight mission success criteria, and post-flight differences in crew 
members’ schedules‖ (Williams & Flynn 1999), which may increase the frequency and severity of 
symptoms related to asthenia. 
In view of this situation, it was obvious that to determine the importance of continuing research on 
asthenia as a problem that might affect the optimal psychological functioning of crew members on long-
duration space flight missions, it was necessary to do a systematic and comprehensive international 
literature review and conduct structured interviews with experts from around the world. The following is 
a summary of the review that was conducted, as well as a description of the interviews with researchers 
that were completed. The literature that was reviewed and researchers who participated in this project 
represented many countries including Canada, Germany, Spain, Japan, Czech Republic, Russia, New 
Zealand, and the United States. Important national and international literature in English, as well as non-
English-language materials including journals, books, magazines, and conference reports, were reviewed. 
This report was a collaborative international work effort focused on the evaluation and determination of 
the importance of continuing research on asthenia as a possible psychological problem that might affect 
the optimal psychological functioning of crew members during long-duration space flight missions. To 
that end, this report first describes the different definitions of asthenia that currently exist by examining 
the current literature on this topic; interviews that were conducted to represent the different multicultural 
perspectives of this issue are then summarized. Conclusions and recommendations specific to both the 
literature review that was completed and the interviews that were conducted are then discussed. In 
particular, the authors suggest that if this review conducted by the BHP Research Element finds enough 
evidence of asthenia in space, it is our duty to develop countermeasures to assess, predict, diagnose, 
monitor, and treat this condition in space, utilizing collaborative research projects both nationally and 
internationally.  
Defining Asthenia 
The word asthenia (from Greek a-, without + sthenos, force), or ―lack of energy,‖ has been used for 
centuries worldwide to name concepts in areas like philosophy, medicine, and psychology (Berrios 2008, 
Boisser De Sauvages 1763, Brown 1804, Coutanceau 1821, Pinel 1812, Roche 1829, Silverman 1989). In 
the realm of psychology, the concept of asthenia has been adopted around the world and modified by 
cultural factors on the basis of subjective experience, making asthenia not only a difficult concept to 
define but also difficult to diagnose. Such subjectivity in the definition of asthenia has produced new 
                                                          
1
 It should be noted that all classification and diagnostic systems have limitations; accordingly, the DSM system 
recognizes its limitations and thus continues to evolve.  
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clinical disorders and descriptions such as neurasthenia (Arndt 1885, Verhaest & Pierloot 1981), 
psychasthenia (Berrios 1989, Haustgen 2004, Lantéri-Laura 1994, Oulahbib 2008), mental overexertion 
(Binet & Henri 1898), the so-called diseases of energy (Deschamps 1919, Deschamps & Vinchon 1932, 
Stiller 1907), aboulia (Berrios & Gili 1995), the fatigue syndromes (Berrios 1989, Bugard 1960), 
shinkeisui-jaku (Tsung 1989), shenjing shuairuo (APA 1994), neurocirculatory dystonia (Krapivnitskaya 
2006), myasthenia (Drachman 2008), Gulf war syndrome (Hotopf et al. 2003), burnout syndrome 
(Freudenberger 1974), atypical depression (Angst 2002), and ―a case of nerves‖ (Murray 1978). In 
addition, recent research has been instigated to explore new symptoms, syndromes, and diseases. 
Asthenia has also been considered synonymous with neurasthenia, major depression, chronic fatigue 
syndrome, and dysthymia, among other diseases. To illustrate the complexity of the topic of asthenia and 
its diversity in multiple cultures, Table 1 presents several definitions from around the world, including the 
medical, psychological, and psychiatric perspectives on this topic.  
Table 1. Definitions of Asthenia and Related Terms 
 
Term Reference  Definition Quoted Field  Country 
Asthenia  Brown 1804  Asthenic diseases were caused by insufficient 
exciting power and had to be treated by strong 
stimulants, notably opium and alcohol; 
“sthenic” diseases were caused by an excess of 
the exciting power.  
Physiology  U.S.  
Asthenia  Tiganov 1975  Asthenia is a state characterized by heightened 
susceptibility to fatigue, fast onset of 
exhaustion, and partial or total loss of capacity 
for prolonged physical activity or mental 
exertion. Asthenia is a syndrome that should be 
viewed as an adaptive reaction due to 
exhaustion of the nervous system as a result of 
overexertion, lack of proper nutrition, 
disruptions in intracellular metabolism, and 
intoxication. 
Space 
psychology  
Russia  
Asthenia Aleksandrovskiy 
1976  
Three stages of asthenia are described: 
 
Stage one: (Hyperesthesia) There is a general 
increase in sensitivity to external stimuli, 
resulting in hyper-arousal and increased 
(sometimes pointless) activity, emotional 
instability and irritability, impatience, 
decreased memory, poor attention and 
concentration, fatigue, headaches, perspiration, 
instability of pulse and blood pressure, and 
sleep disturbances. 
 
Stage two: Irritable weakness, irritability, and 
emotional instability progress into more severe 
fatigue, negative emotional reactions, and 
somnolence.  
Psychology- 
psychiatry 
Russia 
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Stage three: There is indifference and inertness, 
apathy, constant fatigue, passiveness, and lack 
of work capability.  
Asthenia  Encyclopedic 
Dictionary of 
Medicine Terms 
1982  
Asthenia is a state characterized by increased 
susceptibility to fatigue, frequent change of 
mood, irritable weakness, hyperesthesia, 
tearfulness, and autonomic nervous system and 
sleep disorders. 
Physiology  Russia  
Asthenia Voloshina 1989 The definition of asthenia is based on 
etiological criteria: psychogenic, physiogenic, 
somatogenic, and cerebrogenic asthenias result 
from the impact of extreme factors, causing 
maladaptation, especially when cosmonauts’ 
roles are unequal. 
 
Psychogenic: Occurred when a psycho-
traumatic factor was dominant. Is associated 
with apparent emotional instability, manifested 
in irritability or excitability with aggressive 
tendencies or extreme resentfulness and 
tearfulness. 
 
Physiogenic: Occurred as a result of gradual 
fatigue accumulation caused by overwhelming 
physical and mental strain. Decrease in 
performance and increase in asthenic 
phenomena presented and worsened after 
periods of hard work, and subsided after rest. 
 
Somatogenic: A correlation between asthenia 
and the phase as well as the intensity of a 
physical illness was observed, while asthenic 
symptoms had a tendency toward becoming 
more complex.  
 
Cerebrogenic: Occurred in subjects who in the 
past had experienced cranial trauma, 
arachnoiditis, and other central nervous system 
impairments that did not expressly manifest as 
organic symptoms, as well as subjects with 
cerebrovascular disorders of various intensity 
deemed of insufficient significance during pre-
employment selection.  
Asthenia in these subjects was characterized by 
Physiology Russia 
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acute irritability, sleep disturbances, and 
dysfunction of the autonomic nervous system.  
 
Three variants of asthenia: 
 
Non-pathological adaptational asthenic 
restrictions. Manifested as a decreased 
capability of psychological adaptation 
mechanisms to counter the impact of extreme 
conditions. The rate of function recovery in 
these cases largely depended on the degree of 
psychogenesis, fatigue level, physical 
predisposition, and severity of physical illness.  
 
Preexisiting asthenic state: Encompassed pre-
morbid form of adjustment disorders caused by 
adaptation mechanism breakdown and 
functional exhaustion of individual’s 
psychological adaptation defense mechanisms. 
Increased polymorphism of symptoms. 
 
Asthenic disorder: Clinical forms of borderline 
neuropsychiatric disorders.  
Asthenia Aleksandrovskiy 
& Novikov 1996  
Partial asthenia is a mild form of asthenia 
(hyposthenia) that develops in many 
cosmonauts after 1 or 2 months of flight. The 
hyposthenic state is one in which inhibitory 
processes predominate and is characterized by 
fatigue, decreased work capacity, sleep 
problems, anxiety, autonomic disturbance, 
attention and concentration difficulties, and 
heightened sensitivity to bright lights and loud 
noises.  
Space 
psychology 
Russia 
Asthenia Myasnikov & 
Zamaletdinov 
1996 
Asthenia is defined as “an abnormal state 
marked by weakness, increased tendency to 
fatigue, irritability, and disorders of attention 
and memory.” Asthenia is distinct from normal 
fatigue.  
Psychology- 
psychiatry 
Russia 
Asthenia Gordeev et al. 
2003 
Asthenia is characterized by abnormal 
spontaneous fatigue and easy physical and 
mental fatigability that develops after minimal 
physical and mental work. It persists for a long 
time, and does not disappear after rest. It also 
includes emotional lability, increased anxiety, 
reduced motivation, sleep and memory 
Physiology Russia 
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disorders, and impaired concentration. 
Asthenia violates physical and mental capacities 
and affects the patient’s life and social activity. 
“Asthenia is often associated with psycho-
autonomic syndrome (autonomic dystonia) and 
underlies the development of somatic and 
neurological disorders (Vein 1991). As 
differentiated from physiological fatigue, 
asthenia syndrome requires medical 
treatment.” 
Asthenia or 
asthenization  
Petrovsky & 
Yaroshevsky 
1987 (p. 28)  
“Nervous or mental weakness manifesting itself 
in tiredness… and quick loss of strength, low 
sensation threshold, extremely unstable 
moods, and sleep disturbance. [Asthenia] may 
be caused by somatic disease as well as 
excessive mental or physical strain, prolonged 
negative emotional experience, or conflict.” 
Psychology-
psychiatry 
Russia 
Neurasthenia  Beard 1880 This author lists a set of 30 symptoms to 
diagnose neurasthenia, including dilation, 
abnormal activity, sick headache, pain pressure, 
heaviness in the back of the head, change in the 
expression of the eye, disturbance of the nerves 
of special sense, deficient mental control, 
mental irritability, hopelessness, morbid fear 
(the result of various functional diseases of the 
nervous system, implying a debility, weakness, 
incompetency, and inadequacy compared with 
the normal state of the individual), flushing and 
fidgetiness, insomnia, drowsiness, nervous 
exhaustion, feeling of profound exhaustion 
unaccompanied by positive pain, vague pains, 
and flying neuralgias. 
Physiology  U.S. 
Neurasthenia  Drachman 2008 Neurasthenia is the historic term for a 
myasthenia-like fatigue syndrome without an 
organic basis. These patients may present with 
subjective symptoms of weakness and fatigue, 
but muscle testing usually reveals the "jerky 
release" or "give-away weakness" characteristic 
of nonorganic disorders.  
Physiology U.S. 
Neurasthenia  Morant et al. 
1993 
Asthenia is a pathological fatigue, also 
associated with various non-neoplastic 
diseases, particularly with acute or chronic 
infections. Symptoms include weakness, need 
to rest, lack of concentration, lack of appetite, 
problems with sleep, anxiety, and depression.  
Physiology  Switzerland  
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Neurasthenia  WHO 2010 
(ICD-10) 
Considerable cultural variations occur in the 
presentation of this disorder, and two main 
types occur, with substantial overlap:  
 
1) The main feature is a complaint of increased 
fatigue after mental effort, often associated 
with some decrease in occupational 
performance or coping efficiency in daily tasks. 
The mental fatigue is typically described as an 
unpleasant intrusion of distracting associations 
or recollections, difficulty in concentrating, and 
generally inefficient thinking.  
 
2) The emphasis is on feelings of bodily or 
physical weakness and exhaustion after only 
minimal effort, accompanied by a feeling of 
muscular aches and pains and inability to relax.  
In both types, a variety of other unpleasant 
physical feelings is common — feelings such as 
dizziness, tension headaches, and feelings of 
general instability. Worry about decreasing 
mental and bodily well-being, irritability, 
anhedonia, and varying minor degrees of both 
depression and anxiety are all common. Sleep is 
often disturbed in its initial and middle phases, 
but hypersomnia may also be prominent.  
Psychology-
psychiatry 
Worldwide  
Neuropsychiatric 
asthenia  
Encyclopedic 
Dictionary of 
Medicine Terms 
1982  
Neuropsychiatric asthenia is a decrease in 
functional capabilities of the central nervous 
system manifested in reduced performance, 
mental fatigue, worsening of attention and 
memory, and hyper-reactivity with irritable 
weakness, that occurs after serious illness or 
trauma or as a result of psycho-emotional 
overexertion.  
Physiology  Russia  
Psycho-asthenia  Encyclopedic 
Dictionary of 
Medicine Terms 
1982  
Psycho-asthenia is asthenia manifesting as 
increased susceptibility of psychological 
processes to exhaustion and delay in recovery, 
which occurs in combination with hyperesthesia 
and emotional lability.  
Physiology  Russia  
Psycho-asthenia  Alexandrovskiy 
& Novikov 1997  
Psycho-asthenia often refers to problems in 
adapting to new external and internal factors 
(psychological maladaptation), meaning, 
essentially, asthenia that does not produce any 
psychotic disorders or major 
psychopathological disorders.  
Space 
psychology  
Russia  
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Psycho-asthenia 
/ asthenia  
Myasnikov & 
Stepanova 2000  
One distinguishing characteristic of asthenia 
syndrome is irritable weakness, which is 
expressed as elevated excitability, quickly 
changing (unstable) moods, and irascibility. All 
these expressions intensify in the afternoon or 
closer to the evening. The mood is usually low 
with some traces of petulancy and 
dissatisfaction. Asthenia syndrome is frequently 
accompanied by headaches and sleep 
disturbances that present as increased 
sleepiness or persistent insomnia, as well as low 
tolerance for bright light, loud noises, and sharp 
aromas. 
 
Asthenia syndrome in space can be indentified 
in three different stages:  
 
First stage: Expressed primarily as a heightened 
emotional excitability. 
 
Second stage: Characterized by a set of 
symptoms, at the heart of which are mood 
swings, frequent fatigue, decrease in 
performance quality, and signs of sleep 
disturbance.  
 
Third stage: Consistently low mood, expressed 
irritability, conflict tension, hypochondriac 
phenomena, frequent and significant errors in 
performing work-related tasks, and expressly 
manifested sleep disturbances (requiring 
systematic use of sleep aid medication).  
Space 
psychology  
Russia  
shenjing 
shuairuo  
APA 2000 
(DSM-IV-TR) 
A condition characterized by physical and 
mental fatigue, dizziness, headaches, other 
pains, concentration difficulties, sleep 
disturbance, and memory loss.  
Psychology- 
psychiatry 
Japan  
shinkeisui-jaku  Tsung 1989  A psychological reaction developed in a certain 
type of personality characterized by 
hypersensitivity, introversion, self-
consciousness, perfectionism, and 
hypochondriacal disposition.  
Psychology- 
psychiatry 
China  
 
The first and most important conclusion from this table is that asthenia or neurasthenia does exist as a 
psychopathology despite the lack of recognition of it as such by some countries (including the United 
States and Canada). The authors also found that asthenia has considerable cultural variations; therefore, 
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the diagnosis and treatment vary significantly depending on the physician’s medical specialty and 
country. For example, from the Russian space psychology perspective, ―psychoasthenia‖ does not 
produce any psychotic disorders or major psychopathological disorders (Alexandrovskiy & Novikov 
1997). On the other hand, Russian physiologist Gordeev (2003) states that asthenia does not disappear 
after rests and requires medical treatment. In Japan, neurasthenia (shinkeisui-jaku) is treated with rest, 
nutrition, improved hygiene, adjustment of work and lifestyle, and psychotropic medication (Yew 
Schwartz 2002). In China, neurasthenia has been reported to be the second most important diagnosis in 
psychiatric hospitals (Lin 1992, Ware & Kleinman 1992). In far Eastern countries, neurasthenia is 
considered a curable physical condition with a biologic explanation and without the stigma of a 
psychiatric diagnosis (Flaskerud 2007). In a study conducted in Australia, Hickie and colleagues (2002) 
concluded that neurasthenia is typically chronic and is associated with high levels of co-morbid affective 
and anxiety disorders.  
 
Despite the demonstration by epidemiological studies that neurasthenia is a common psychopathology in 
many countries, questions remain for NASA, including: a) Does asthenia, neurasthenia, or psycho-
asthenia exist in space? b) Will astronauts or cosmonauts develop asthenia (partial or full) on long-
duration space flight missions? c) If asthenia does exist, can it be prevented?  
Asthenia Symptom Analysis and Comparison with Depression, Anxiety, Chronic Fatigue, 
and Psychosomatic Illness 
During this literature review, more than 22 definitions were collected for asthenia: 11 were from the 
physiology field, six were from the psychiatry/psychology field, and five were used specifically in the 
space psychology literature. However, it should be noted that all the asthenia or psycho-asthenia 
definitions utilized for space psychology were Russian
2
 (Table 2). 
 
  
                                                          
2
 The only definitions of asthenia in space were described by Russian authors. 
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Table 2. Symptoms of Asthenia According to Different Authors 
 
  Reference number 
Symptoms  1 2 3 4 5 6 7 8 9 
1
0 
1
1 
1
2 
1
3 
1
4 
1
5 
1
6 
1
7 
1
8 
1
9 
2
0 
2
1 
2
2 
                       
Aggressive tendency                   *                         
Anxiety symptoms            *   *                       *   * 
Apathy                 *                           
Autonomic disturbance               *                             
Debility     * *                                     
Decrease in occupational 
performance 
        *     * * * *   *     *             
Deficient mental control     *                                       
Depression symptoms 
(minimal)                               *         * * 
Difficulty concentrating         * * * * *       *       *     * * * 
Dizziness          *                       *         * 
Drowsiness     *                                       
Elevated excitability                               *             
Emotional lability           *       *       *                 
Excessive mental strain       *           * *           *           
Excessive physical strain       *           * *           *           
Exhaustion                     *     *                 
Exhaustion after minimal 
effort 
        * *                                 
Fatigue (non-organic base) *           * * * * * *       *       *     
Fatigue after mental effort         * *             *                   
Feelings of instability         *                                   
Headache     *           *               *         * 
Heightened sensitivity to 
bright lights and noises                *               *             
Hopelessness      *                                       
Hyperactivity                          *                   
Hyperarousal                 *                 *         
Hyperesthesia                       *   *                 
Impatience                 *                           
Inability to relax         *                                   
Inefficient thinking         *                                   
Insomnia     *                         *           * 
Insufficient power    *                                         
Irascibility                               *             
Irritability         *   *   * *                     * * 
Irritable weakness                       * *       *           
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Lack of appetite                                       *   * 
Lassitude                                         *   
Memory disorder           * *   *       *       *           
Mental irritability      *                                       
Morbid fears (phobias)     *                                       
Muscular aches         *                                   
Nervous exhaustion     *                                       
Nervous or mental weakness       * *                                   
Pain pressure      *                                       
Prolonged negative 
emotional experience       *         *                           
Reduced motivation           *                                 
Requires medical treatment           *                                 
Sensitivity to external stimuli                 *                           
Sleep disturbance       * * *   * *     *       * *           
Somatic disease       *   *                   *   *   * *   
Symptoms develop after 1 or 
2 months 
              *                             
Symptoms develop because 
of lack of nutrition                                     *       
Symptoms develop because 
of adaptive reaction               *   *         *       *       
Symptoms don’t disappear 
after rest 
          *                                 
Symptoms persist for long 
time 
          *               *                 
Tearfulness                   *   *                     
Tiredness       *                                     
Unstable mood       *         *     *       *             
Vague pain     *                                       
Weakness *   *   *   *                         *     
Worry                                         *   
 
We found 62 different symptoms that define asthenia, neurasthenia, or psycho-asthenia. Among all the 
symptoms, not a single symptom was consistent with all of the definitions that described asthenia, 
neurasthenia, or psychoasthenia. For that reason, our analysis found that the six most prevalent symptoms 
were difficulty concentrating, fatigue (non-organic related), sleep disturbance, decrease in occupational 
performance, somatic disease, and irritability (Table 3). The next most prevalent group of symptoms 
consisted of weakness, memory disorders, headache, excessive mental strain, excessive physical strain, 
and symptoms that developed because they were part of an adaptive reaction (Table 4).  
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Table 3. Frequency (number of references in Table 2) of the Most Prevalent (primary)Symptoms of Asthenia 
Primary Symptoms Frequency 
Fatigue 9 
Sleep disturbance 8 
Somatic disease 6 
Difficulty concentrating 10 
Decrease in occupational performance 7 
Irritability 6 
 
Table 4. Frequency (number of references in Table 2) of the Most Prevalent Secondary Symptoms of Asthenia 
Secondary Symptoms  Frequency 
Weakness 5 
Memory disorder 5 
Headache 4 
Excessive mental strain 4 
Excessive physical strain 4 
Anxiety symptoms  4 
Symptoms developed as part of an adaptive reaction 4 
 
G. Beard, the pioneer of asthenia research, wrote in 1880, ―As we saw such diversity of symptoms, 
sensation or conditions cannot properly be thus grouped together to constitute a special and so-called new 
disease, under any name, not even neurasthenia (…) and maybe [it] is because since the beginning of the 
neurasthenia definition, the symptoms of neurasthenia have never yet been fully described.‖ (Beard 1880) 
In the second part of our analysis of the asthenia literature, we contrasted asthenia with psychological 
disorders that historically are associated with it and are presented in different diagnostic systems, 
including the DSM. These comparisons aim to accept or reject the idea that asthenia is or is not 
depression, general anxiety, dysthymia, chronic fatigue, or a psychosomatic disorder.  
To find out if asthenia is a psychological condition that might arise during a long-duration space mission, 
we compared common symptoms of asthenia with the current criteria for those psychiatric conditions that 
are used in different diagnostic systems such as the DSM, ICD, and the Annals of Internal Medicine.  
Depression 
According to the DSM-IV-TR, to be diagnosed with major depression, it is necessary to present five (or 
more) symptoms during the same 2-week period, and at least one of the symptoms must be (1) depressed 
mood or (2) loss of interest or pleasure. Comparing the DSM criteria for depression (Table 5) with the 
symptoms of asthenia, we found that criteria C, D, and E were met by asthenia. In criterion A, we found 
three similar symptoms (fatigue, decrease in appetite, diminished ability to think or concentrate). It is 
necessary to emphasize that the diagnosis of major depression does not match that of the asthenia 
syndrome in full because of the duration of the symptoms (in the case of depression, only a 2-week period 
is required). Comparing the ICD-10 criteria for depression with asthenia symptoms, we found four similar 
symptoms (decreased energy or increased fatigability, diminished ability to think or concentrate, sleep 
disturbance of any type, and change in appetite). Thus, neither the DMS nor the ICD criteria for major 
depression were met in full as is evidenced in Table 5 below.  
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Table 5. Criteria for a Diagnosis of Depressive Episode, in the DSM-IV-TR and the ICD-10 
Depressive Episode  
DSM-IV-TR ICD-10
3
 
A. Five (or more) of the following symptoms have been 
present during the same 2-week period and 
represent a change from previous functioning; at 
least one of the symptoms is either (1) depressed 
mood or (2) loss of interest or pleasure. 
1) Depressed mood most of the day, nearly every 
day, as indicated by either subjective report (e.g., 
feels sad or empty) or observation made by others 
(e.g., appears tearful). Note: In children and 
adolescents, can be irritable mood. 
2) markedly diminished interest or pleasure in all, or 
almost all, activities most of the day, nearly every 
day (as indicated by either subjective account or 
observation made by others) 
3) significant weight loss when not dieting or weight 
gain (e.g., a change of more than 5% of body weight 
in a month), or decrease or increase in appetite 
nearly every day. Note: In children, consider failure 
to make expected weight gains. 
4) insomnia or hypersomnia nearly every day 
5) psychomotor agitation or retardation nearly every 
day (observable by others, not merely subjective 
feelings of restlessness or being slowed down) 
6) fatigue or loss of energy nearly every day 
7) feelings of worthlessness or excessive or 
inappropriate guilt (which may be delusional) nearly 
every day (not merely self-reproach or guilt about 
being sick) 
8) diminished ability to think or concentrate, or 
indecisiveness, nearly every day (either by subjective 
account or as observed by others) 
9) recurrent thoughts of death (not just fear of 
dying), recurrent suicidal ideation without a specific 
plan, or a suicide attempt or a specific plan for 
committing suicide  
B. The symptoms do not meet criteria for a Mixed 
Episode. 
C. The symptoms cause clinically significant distress or 
impairment in social, occupational, or other 
The general criteria for depressive episode (F32) must 
be met. 
B. At least two of the following three symptoms must 
be present: (1) depressed mood to a degree that is 
definitely abnormal for the individual, present for most 
of the day and almost every day, largely uninfluenced 
by circumstances, and sustained for at least 2 weeks. (2) 
loss of interest or pleasure in activities that are 
normally pleasurable; (3) decreased energy or increased 
fatigability. 
C. An additional symptom or symptoms from the 
following list should be present, to give a total of at 
least four: (1) loss of confidence and self-esteem; (2) 
unreasonable feelings of self-reproach or excessive and 
inappropriate guilt; (3) recurrent thoughts of death or 
suicide, or any suicidal behavior; (4) complaints or 
evidence of diminished ability to think or concentrate, 
such as indecisiveness or vacillation; (5) change in 
psychomotor activity, with agitation or retardation 
(either subjective or objective); (6) sleep disturbance of 
any type; (7) change in appetite (decrease or increase) 
with corresponding weight change. 
 
 
                                                          
3
 http://www.who.int/classifications/icd/en/GRNBOOK.pdf 
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important areas of functioning. 
D. The symptoms are not due to the direct 
physiological effects of a substance (e.g., a drug of 
abuse, a medication) or a general medical condition 
(e.g., hypothyroidism). 
E. The symptoms are not better accounted for by 
Bereavement (i.e., after the loss of a loved one), the 
symptoms persist for longer than 2 months or are 
characterized by marked functional impairment, 
morbid preoccupation with worthlessness, suicidal 
ideation, psychotic symptoms, or psychomotor 
retardation. 
 
General Anxiety 
We found that only criteria D, E, and F for general anxiety disorder in the DSM were similar to asthenia 
symptoms. Criterion C shares four symptoms with asthenia (easily becoming fatigued or worn out, 
concentration problems, irritability, and difficulty with sleep). However, the duration of symptoms does 
not correspond with the time criterion for asthenia. When considering ICD-10, on the other hand, only 
criterion B was met, with five symptoms corresponding with the asthenia criteria (muscle tension or aches 
and pains, feeling dizzy, restlessness, inability to relax, difficulty in concentrating, persistent irritability). 
This evidence corroborates early arguments that asthenia and general anxiety are not similar.  
Table 6. Criteria for a Diagnosis of General Anxiety, in the DSM-IV-TR and the ICD-10 
General Anxiety  
DSM-IV-TR ICD-10 
A. At least 6 months of "excessive anxiety and worry" 
about a variety of events and situations. Generally, 
"excessive" can be interpreted as more than would be 
expected for a particular situation or event. Most 
people become anxious over certain things, but the 
intensity of the anxiety typically corresponds to the 
situation.  
 
B. There is significant difficulty in controlling the anxiety 
and worry. If someone has a very difficult struggle to 
regain control, relax, or cope with the anxiety and 
worry, then this requirement is met.  
 
C. The presence for most days over the previous 6 
months of 3 or more (only 1 for children) of the 
following symptoms:  
1. Feeling wound-up, tense, or restless 
A. A period of at least 6 months with prominent 
tension, worry and feelings of apprehension, about 
everyday events and problems. 
B. At least four symptoms out of the following list of 
items must be present, of which at least one must be 
from items (1) to (4). 
Autonomic arousal symptoms 
(1) Palpitations or pounding heart, or accelerated heart 
rate. (2) Sweating. (3) Trembling or shaking. (4) Dry 
mouth (not due to medication or dehydration). 
Symptoms concerning chest and abdomen 
(5) Difficulty breathing, (6) Feeling of choking, (7) Chest 
pain or discomfort, (8) Nausea or abdominal distress 
(e.g., churning in stomach). 
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2. Easily becoming fatigued or worn-out 
3. Concentration problems 
4. Irritability 
5. Significant tension in muscles 
6. Difficulty with sleep 
D. The symptoms are not part of another mental 
disorder.  
 
E. The symptoms cause "clinically significant distress" or 
problems functioning in daily life. "Clinically significant" 
is the part that relies on the perspective of the 
treatment provider. Some people can have many of the 
aforementioned symptoms and cope with them well 
enough to maintain a high level of functioning.  
 
F. The condition is not due to a substance or medical 
issue. 
Symptoms concerning brain and mind 
(9) Feeling dizzy, unsteady, faint or light-headed, (10) 
Feelings that objects are unreal (derealization), or that 
one’s self is distant or "not really here" 
(depersonalization), (11) Fear of losing control, going 
crazy, or passing out, (12) Fear of dying. 
General symptoms  
(13) Hot flushes or cold chills, (14) Numbness or tingling 
sensations. 
Symptoms of tension 
(15) Muscle tension or aches and pains, (16) 
Restlessness and inability to relax, (17) Feeling keyed 
up, or on edge, or of mental tension, (18) A sensation of 
a lump in the throat, or difficulty with swallowing. 
Other non-specific symptoms 
(19) Exaggerated response to minor surprises or being 
startled, (20) Difficulty in concentrating, or mind going 
blank, because of worrying or anxiety, (21) Persistent 
irritability, (22) Difficulty getting to sleep because of 
worrying. 
Dysthymia 
Five symptoms of DSM-IV-TR dysthymic disorder were similar to those of asthenia: low energy or 
fatigue, poor appetite or overeating, insomnia or hypersomnia, and poor concentration and feelings of 
hopelessness. However, the criteria for dysthymic disorders required a duration of 2 years, which does not 
match the asthenia criteria. Of the ICD-10 criteria for dysthymia, only criterion C had symptoms in 
common with asthenia, but it had five: insomnia, difficulty concentrating, loss of interest or enjoyment in 
sex and other pleasurable activities, feeling of hopelessness or despair, and perceived inability to cope 
with the routine responsibilities of everyday life. But again, because a patient diagnosed with dysthymia 
needs to have had symptoms continuously for 2 years, we can also conclude that dysthymia and asthenia 
are not the same.  
 
Table 7. Criteria for a Diagnosis of Dysthymia, in the DSM-IV-TR and the ICD-10 
Dysthymia 
DSM-IV-TR ICD 
A. Depressed mood most of the day, for more days than 
not, as indicated either by subjective account or 
observation by others, for at least 2 years. Note: In 
children and adolescents, mood can be irritable and 
A period of at least 2 years of constant or constantly 
recurring depressed mood. 
Intervening periods of normal mood rarely last for 
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duration must be at least 1 year. 
B. Presence, while depressed, of two (or more) of the 
following: 1) poor appetite or overeating, 2) insomnia 
or hypersomnia, 3) low energy or fatigue, 4) low self-
esteem, 5) poor concentration or difficulty making 
decisions, 6) feelings of hopelessness.  
C. During the 2-year period (1 year for children or 
adolescents) of the disturbance, the person has never 
been without the symptoms in Criteria A and B for more 
than 2 months at a time. 
B. No symptoms have  been present during the first 2 
years of the disturbance (1 year for children and 
adolescents); i.e., the disturbance is not better 
accounted for by chronic , or Major Depressive 
Disorder, In Partial Remission. 
 
longer than a few weeks and there are no episodes of 
hypomania. 
B. None, or very few, of the individual episodes of 
depression within such a 2-year period are severe 
enough, or last long enough, to meet the criteria for 
recurrent mild depressive disorder (F33.0). 
C. During at least some of the periods of depression at 
least three of the following should be present: 1) A 
reduction in energy or activity; (2) Insomnia; (3) Loss of 
self-confidence or feelings of inadequacy; (4) Difficulty 
concentrating; (5) Often in tears; (6) Loss of interest or 
enjoyment in sex and other pleasurable activities; (7) 
Feeling of hopelessness or despair; (8) A perceived 
inability to cope with the routine responsibilities of 
everyday life; (9) Pessimistic about the future or 
brooding over the past; (10) Social withdrawal; (11) Less 
talkative than normal. 
 
Chronic Fatigue Syndrome 
Chronic fatigue syndrome is not mentioned nor included as a mental disorder in the ICD-10 nor in the 
DSM-IV-TR. In our literature analysis we found that, according to a resource document published in the 
Annals of Internal Medicine
4
 (Fukuda et al. 1994), chronic fatigue shares three major criteria symptoms 
(fatigue not due to ongoing exertion, fatigue not substantially relieved by rest, and substantial reduction in 
occupational, educational, social, or personal activities) and three minor criteria symptoms (self-reported 
impairment in short-term memory or concentration severe enough to reduce activities, unrefreshing sleep, 
and muscle pain) with asthenia. However, the criteria for chronic fatigue were not met by asthenia. In 
addition, the duration of symptoms (6 months) does not correspond with that of asthenia (Table 8).  
Table 8. Criteria for a Diagnosis of Chronic Fatigue, in the Annals of Internal Medicine Article and the ICD-10 
 
Chronic Fatigue 
Annals of Internal Medicine
5
 (Fukuda et al. 1994) ICD 
Diagnosis requires all four major criteria and at least 
four minor criteria (persistent or recurrent during at 
least 6 consecutive months but not predating fatigue), 
else considered idiopathic chronic fatigue  
Major criteria: 1) unexplained, persistent or relapsing 
Note: There is not a chronic fatigue listing in the ICD-10. 
Some authors will suggest that chronic fatigue in the 
DSM is the equivalent of neurasthenia in the ICD. 
However, the ICD defines neurasthenia differently.  
                                                          
4
Annals of Internal Medicine is an academic medical journal published by the American College of Physicians. The 
journal had a 2008 impact factor of 16.2, which makes it among the most cited of general clinical medical journals. 
5
 Fukuda et al. 1994. 
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chronic fatigue that is new or of definite onset (not 
lifelong); 2) fatigue not due to ongoing exertion; 3) 
fatigue not substantially relieved by rest; 4) substantial 
reduction in occupational, educational, social, or 
personal activities.  
Minor criteria: 1) self-reported impairment in short-
term memory or concentration severe enough to 
reduce activities; 2) sore throat; 3) tender cervical or 
axillary lymph nodes; 4) muscle pain; 5) multijoint pain 
without joint swelling or tenderness; 6) headaches of 
new type, pattern, or severity; 7) unrefreshing sleep; 8) 
postexertional malaise lasting > 24 hours; 9) temporary 
medical exclusions; 10) conditions that can be 
corrected; for example, medication effects, sleep 
deprivation, untreated hypothyroidism, untreated or 
unstable diabetes mellitus, active infection; 11) 
conditions that resolve; for example, pregnancy until 3 
months postpartum, breastfeeding, major surgeries 
until 6 months post surgery, minor surgeries until 3 
months post surgery, major infections until 3 months 
post resolution; 12) sleep disorders; for example, 
restless leg syndrome or periodic limb movement; 13) 
myocardial infarction (resolution may be unclear for at 
least 5 years); 14) morbid obesity (BMI > 40 kg/m
2
)  
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These are the main conclusions about the foregoing symptom comparisons: 
 The Annals of Internal Medicine article, the DSM, and the ICD (aside from the fact that they have 
similar diagnostic criteria with regard to duration of symptoms) have many differences in the way 
they describe psychiatric pathology.  
 Although depressive episodes, anxiety, chronic fatigue, and dysthymia share similar symptoms, 
they do not share a similarity to asthenia with regard to time and specifically the duration of 
symptoms.  
 It is difficult to define asthenia, neurasthenia, or psycho-asthenia as a psychological syndrome in 
space, because most space flight missions (excluding many Russian missions) have durations less 
than or equal to 6 months and most of the symptoms of this syndrome would not necessarily 
occur in that timeframe.  
Methodological Approach and Results: Literature Review and 
Structured Interviews 
To determine the importance of continuing research on asthenia as a possible problem that might affect 
the optimal psychological functioning of crew members on long-duration space flight missions, it was 
necessary to do a systematic, extensive international literature review that included conducting structured 
interviews with experts from around the world. Literature was reviewed from many countries, including 
Canada, Germany, Spain, Japan, France, Czech Republic, Russia, United States, U.K., Australia, and 
Switzerland. In addition, subject matter experts were interviewed and represented many countries as well, 
including Canada, Germany, Spain, Japan, Czech Republic, Russia, and United States. 
The comprehensive, systematic literature review had six phases:  
 Phase 1: Define inclusion and exclusion criteria. 
 Phase 2: Collect relevant articles. 
 Phase 3: Conduct initial evaluation of collected articles. 
 Phase 4: Conduct structured interviews with experts. 
 Phase 5: Analyze and interpret articles and interviews.  
 Phase 6: Produce results to develop the final report.  
We examined physical, psychological, and psychiatric literature that reported studies involving astronauts 
and cosmonauts in short- and long-duration space flight missions.  
Inclusion criteria:  
1. Sources of documents: scientific journals, conferences, books, magazines, and newspapers, 
containing reports on empirical or quantitative studies with astronauts and cosmonauts 
2. Time period: 1850 to 2010 
3. Databases that were searched: PsychInfo, Psycharticle, ISI Web of Knowledge, PubMed, 
DynaMed, Access Medicine, MD Consult, STATREF, Diagnosaurus, East View Information 
Services, World Cat, Elsevier, ScienceDirect 
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Exclusion criterion:  
1. Technical reports, books, conferences, newspapers, magazines, dissertations, commentaries, case-
samples, and literature reviews that were not representative of astronaut or cosmonaut 
populations and that were not related to the area of psychology, psychiatry, asthenia, or mental 
health in long- or short-duration space flight missions 
Data collection and analysis: Thirteen major databases (listed above) were examined. The keywords used 
in the systematic analysis were astronaut(s), cosmonaut(s), asthenia, neurasthenia, neurocirculatory 
asthenia, psychoasthenia, space, spaceflight, psychology, psychiatry, long duration missions, short 
duration missions, mental health, chronic fatigue, and trans-cultural diagnosis. The keyword searches 
identified a total of 345 articles. After the inclusion and exclusion criteria were applied, the final articles 
for review numbered 104. Six experts from around the world in the fields of psychiatry, psychology 
(clinical, sport, and neuropsychology), and space medicine, who were either working directly with space 
agencies that help support astronauts or cosmonauts or were involved in analog projects (like Mars 500) 
related to space flight missions, were interviewed utilizing a semi-structured framework.  
Table 9 provides a summary of those interviewed for this project: a flight surgeon from Russia; a 
neuropsychologist from Spain; psychiatrists from Canada, New Zealand, and the United States.; a 
psychologist from Japan; and a sports psychologist from Germany. 
 
Table 9. Researchers Interviewed for this Project 
 
Profession/Job Role Country Affiliation Quotation 
Flight surgeon  Russia Russian Federal Space 
Agency (RFSA) 
“…[T]he way we detect 
the development of 
symptoms is thorough: 
body language, the 
vocabulary they are using, 
human errors, apathy, 
etc…” 
Neuropsychologist Spain European Space 
Agency (ESA)— Mars 
500 mission 
“… [I]t’s time to share 
information about space 
psychology…” 
Psychiatrist United States National Aeronautics 
and Space 
Administration (NASA) 
“…[S]pace flight asthenia 
is a combination of things 
that is common to 
anybody living in an 
isolated environment…”  
Psychiatrist Canada Canadian Space 
Agency 
“…[T]here is always a 
possibility to see 
psychological symptoms 
in long duration missions, 
but I will suspect that the 
incidence will be very low, 
because people are very 
well screened…”  
 
…[O]n the other hand the 
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longer somebody is 
exposed to stress, the 
more probability is that 
someone comes with 
that...”  
Psychologist Japan  Japan Aerospace 
Exploration Agency 
(JAXA) 
“…[I]n case of an 
emergency we rely on the 
USA support…” 
Sports psychologist Germany ESA — Mars 500 
mission 
“…[O]ne good 
countermeasure for 
asthenia can be 
exercise…” 
 
 
Asthenia in Space 
From 1961 until June 15, 2010, more than 500 humans from 38 different countries went into space 
(http://www.nasa.gov/worldbook/astronaut_worldbook.html). Despite these numbers and the valuable 
knowledge and experience gained from those space travels, many psychiatric and psychological questions 
about space travelers have still not been resolved. These include whether crew members will develop 
psychological issues or have the mental strength to deal with crew conflict, asthenia, depression, anxiety, 
and many other psychiatric conditions that will likely occur during long-duration space flight missions. 
There are several reasons why such questions have not been answered. The main reason seems to be that 
the psychological well-being of the astronauts or cosmonauts was not the primary goal of the early 
mission explorations (Santy 1983). Although it has been proved that humans can survive the extremely 
challenging environment of living in space for a period of weeks, months, or even a year and 10 weeks 
(the record held by Russian cosmonaut Valeri Polyakov, who completed a 438-day tour of duty aboard 
the Mir space station in 1995), it is still unknown if humankind can adapt, survive, and perform 
physically and psychologically on extended-duration missions and/or beyond low Earth orbit.  
Despite all the technological, medical, and psychological improvements (such as Internet protocol 
phones, Internet access, family support packages, and instant communication with ground control) that 
are available in this new era of space exploration to support astronauts and cosmonauts on long-duration 
space flight missions, evidence exists that crew members have developed psychological issues (Stuster, 
2010) during some of these longer missions. The appearances of these new, unexpected psychological 
conditions on long-duration space flight missions have concerned space psychiatrists and psychologists. 
Researchers, primarily from Russia and the United States, have followed these symptoms closely.  
 
Asthenia or neurasthenia is one of the psychological conditions that has been observed, but it has been 
seen only by Russian medical and psychological personnel (Aleksandrovskiy 1976, Grigoriev et al. 1996, 
Kanas et al. 2001, Myasnikov & Zamaletdinov 1996) in cosmonauts after they have spent 4 months living 
in space.  
 
In the mid-1970s, Russian psychiatrists and psychologists considered asthenia a syndrome that should be 
viewed as an adaptive reaction due to exhaustion of the nervous system as a result of overexertion, lack of 
proper nutrition, disruptions in intracellular metabolism, and intoxication (Tiganov 1975). However, 
during this same timeframe, one Russian psychologist defined asthenia as a state characterized by 
heightened susceptibility to fatigue, fast onset of exhaustion, and partial or total loss of capacity for 
prolonged physical activity or mental exertion (Tiganov 1975). A year later, Aleksandrovskiy (1976) 
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stated that asthenia in space develops in three phases: ―Stage one (hyperesthesia): there is a general 
increase in sensitivity to external stimuli, resulting in hyper-arousal and increased (sometimes pointless) 
activity, emotional instability and irritability, impatience, decreased memory, poor attention and 
concentration, fatigue, headaches, perspiration, instability of pulse and blood pressure, and sleep 
disturbances. Stage two: irritable weakness, irritability, and emotional instability progress into more 
severe fatigue, negative emotional reactions, and somnolence. Stage three: there is indifference and 
inertness, apathy, constant fatigue, passiveness, and lack of work capability.‖  
 
Another contribution to observations of asthenia was made by Petrovsky and Yaroshevsky (1987), who 
suggested that ―asthenia is a nervous or mental weakness manifesting itself in tiredness… and quick loss 
of strength, low sensation threshold, extremely unstable moods, and sleep disturbance. [Asthenia] may be 
caused by somatic disease as well as excessive mental or physical strain, prolonged negative emotional 
experience or conflict.‖ Years later, Aleksandrovskiy and Novikov (1996) argued that cosmonauts present 
partial asthenia and it develops after the first or second month of flight. Symptoms included fatigue, 
decreased work capacity, sleep problems, anxiety, autonomic disturbance, attention and concentration 
difficulties, and heightened sensitivity to bright lights and loud noises. Furthermore, Myasnikov & 
Zamaletdinov (1996) defined asthenia as an abnormal state marked by weakness, increased tendency to 
fatigue, irritability, and disorders of attention and memory, making a clear distinction that asthenia is 
different from normal fatigue. Myasnikov (2000) in future studies concluded that the asthenia syndrome 
in space can be identified in three different stages. The first stage is expressed primarily as a heightened 
emotional excitability; the second stage is characterized by a set of symptoms at the heart of which are 
mood swings, frequent fatigue, decrease in performance quality, and signs of sleep disturbance; and the 
third stage is consistently low mood, expressed irritability, conflict tension, hypochondriac phenomena, 
frequent and significant errors in performing work-related tasks, and expressly manifested sleep 
disturbances (requiring systematic use of sleep aid medication). Finally, Myasnikov & Zamaletdinov 
(1996) described the symptoms of asthenia in space as being similar to those affecting patients on the 
ground, and both versions reflected de-adaptation to a stressful environment. They believed that asthenia 
in the clinical setting on Earth was a disorder with neurotic features, and it could be treated with 
medications.  
 
On the other hand, some researchers from the United States. have specifically looked at asthenia in space 
using the Profile of Mood
 
States (POMS) (Kanas et al. 2001). Kanas and colleagues could not 
demonstrate the presence of asthenia in space as operationally defined using the POMS, as the
 
POMS 
addresses only emotional and not physiological aspects
 
of the syndrome (Kanas 1991 & 2003).  
 
Recognition of (and agreement on) psychological symptoms of asthenia before, during, and after long-
duration space missions is crucial for psychiatrists, psychologists, flight surgeons, ground control 
personnel, and astronauts and cosmonauts, as these psychological symptoms can dramatically affect 
crews’ mental and physical well-being and performance during a mission. These psychiatric and 
psychological questions will be unresolved until 1) we recognize different diagnoses from different 
disciplines and countries; 2) we gain more experience with asthenia and more accurately detect, diagnose, 
and treat it as NASA, ESA, JAXA, and RSFA; and 3) the United States overcomes its lack of long-
duration experience.  
 
A) Will astronauts and/or cosmonauts develop asthenia?  
 
Beyond the evidence for development of psychological symptoms such as depression, anxiety, and 
asthenia in astronauts and cosmonauts on long-duration missions (Grigoriev 1996, Myasnikov & 
Zamaletdinov 1996), only Russian physicians have seen the asthenia syndrome in cosmonauts after 4 
months of space flight. NASA flight surgeons, as well as the psychiatrists and psychologists who support 
the missions, have not observed the symptoms (irritability, sleep disorders, fatigue, difficulty 
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concentrating, decrease in occupational performance, and some somatic symptoms) of asthenia together 
to classify them as one syndrome. There are many possible reasons for this, including a) cultural gaps 
exist in our current diagnostic system (DSM) in the United States and therefore in NASA flight medicine; 
b) the current environmental and physical condition of the International Space Station has helped to 
improve the physical and psychological adaptation of the astronauts and cosmonauts; and c) the process 
for selecting and screening astronauts may have influenced the ability to observe these psychological 
conditions in U.S. crew members in space. All these factors are possible, but more research is needed to 
support or refute those arguments.  
 
If we see asthenia as a syndrome or a series of multiple conditions marked by symptoms such as fatigue, 
irritability, and mood swings (Alexandrovskiy & Novikov 1997, Myasnikov 2000), we cannot predict at 
this time that future crews will develop the asthenia syndrome on missions of longer duration. However, 
according to the results of this review, there seems to be a very high probability that at least partial 
asthenia, as defined by Aleksandrovskiy (1976) and by Alexandrovskiy & Novikov (1997), will develop 
after 6 or more months in space. And as was discussed above, these questions will remain only partially 
answered until we send more people on space exploration missions for longer durations.  
 
B) Can we prevent asthenia in space?  
To determine whether asthenia in space is preventable, it was fundamental to establish certain 
information: 1) a clear definition of the problem or syndrome; 2) what symptoms need to be prevented; 
and 3) under which circumstances asthenia (that is, weakness, with an increased tendency to have fatigue, 
irritability, and disorder of attention and memory) appears in space. The first difficulty we encountered in 
attempting to establish this information was the fact that asthenia is not recognized worldwide as a 
syndrome or disorder on Earth. This finding complicates the prevention of asthenia in space because we 
cannot define or know the causes of asthenia. However, we can use the results of the present paper to 
identify the most frequent symptoms associated with asthenia—fatigue, irritability, sleep disorders, 
somatic symptoms, difficulty in concentrating, and a decrease in occupational performance. Attempts at  
preventing asthenia in space can be focused on these symptoms. 
Another way in which asthenia could be prevented in space is by addressing the symptoms as they arise in 
individual astronauts. Russians experts have been addressing prevention in this way for decades. 
Specifically, they monitor symptoms through an analysis of verbal communication, body language, voice, 
and tone between crew members as well as between crew members and mission control (Myasnikov et al. 
2000). Another possible way to prevent asthenia in space is to examine medical records that may include 
symptoms such as fatigue, somatic symptoms, sleep quality, and mood (Kanas 2001) as well as general 
behavior, motor activity, psycho-physiological tension, sensory phenomena, dominant interest, demands 
and complaints, and emotional reactions. At the group level, one can analyze job performance, group 
interaction, group cohesiveness, intergroup control, and group functioning (Myasnikov & Zamaletdinov 
1996).  
 
We can also use international assessment tools that have been used in disciplines outside the fields of 
psychiatry, psychology, and space psychology, such as paper-based survey tools that assess asthenia in 
populations such as cancer patients (Morant et al. 1993), but it is likely that these questionnaires would 
need to be customized for astronauts and cosmonauts to ensure they are valid and sensitive to this unique 
population. Another countermeasure for asthenia could be exercise (S. Schneider, personal 
communication, June 2010). Lastly, we could use antiasthenic medication (Gordeev et al. 2003). 
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Conclusions 
With this report, the BHP Research Element has addressed one of the recommendations made by the 
NASA HRP SRP for the Behavioral Medicine Risk of Psychiatric Disorders, specifically the 
recommendation to complete an evaluation of the ―literature on asthenia …(possibly as a psychological or 
psychosomatic/psycho-physiological analogue of chronic fatigue syndrome).‖ This report makes this 
Element aware of the possible existence of asthenia in space. As the report describes, the concept of 
asthenia has been adopted and modified on the basis of subjective experience by cultures around the 
world, making asthenia a difficult concept to define, and therefore also difficult to diagnose. Nevertheless, 
countries like China, Japan, Russia, Germany, and Switzerland still consider asthenia to be a psychiatric 
condition, although the United States does not.  
The subjectivity in the definition of asthenia has produced new lines of research on clinical disorders and 
descriptions of them. In addition, asthenia has been compared with other psychiatric conditions, but there 
is enough evidence to show that asthenia is a psychopathology on its own, even if asthenia syndrome 
shares some symptoms with other psychopathologies like dysthymia, major depression, anxiety, and 
chronic fatigue (Gamma et al. 2007, Goldberg & Bridges 1991, Harvey et al. 2009, Kleinman 1982). 
Despite the fact that the United States and Russia are the most experienced countries in sending astronauts 
and cosmonauts into space and supporting them, only the Russian program recognizes asthenia, 
neurasthenia, or psycho-asthenia as a possible threat during long-duration missions. This is likely due to 
many reasons, but one reason may be that the Russian space program has more experience sending 
cosmonauts into space for missions of the longest durations so far (6 months or more). The United States 
has limited experience on space flight missions beyond 6 months, and thus has limited observations of 
psychological symptoms that may be experienced during missions of such duration.  
It seems that the experience of isolation and deprivation that crew members can face on missions of less 
than 6 months is completely different from this experience on missions of more than 6 months. On 
missions shorter than 6 months, psychological symptoms seem unlikely to develop. On the other hand, on 
missions longer than 6 months in space, it is possible to observe symptoms of depression, fatigue, and 
general anxiety and asthenia. According to Russian personnel (those who were interviewed), asthenia 
symptoms will develop after 4-month missions; if this is the case, NASA would have a limited window to 
observe if, when, and how those symptoms would develop in the astronaut population. 
In the literature review, we found that not a single symptom was present in all the definitions that describe 
asthenia or neurasthenia. However, some symptoms were more prevalent than others in these definitions. 
The most prevalent symptoms that were found in definitions of asthenia were difficulty concentrating, 
fatigue (non-organic related), sleep disturbance, decrease in occupational performance, somatic disease, 
and irritability. The next most prevalent symptoms were weakness, memory disorders, headache, 
excessive mental strain, excessive physical strain, and symptoms that developed as part of an adaptive 
reaction. 
When we compared asthenia with depression, dysthymia, general anxiety, and chronic fatigue, we found 
that although chronic fatigue has most of the same symptoms as asthenia, asthenia does not share the 
criterion of duration (a patient must have the symptoms of chronic fatigue for 6 months to meet the 
diagnosis criteria). Thus, we can state that asthenia is not chronic fatigue. However, if asthenia symptoms 
continued for more than 6 months, we could make the argument that astronauts and cosmonauts were 
experiencing chronic fatigue syndrome and not asthenia. 
 25 
 
Recommendations  
After doing a comprehensive international literature review on asthenia, we are open to the possibility that 
asthenia symptoms occur in astronauts on long-duration missions; however, because a gap exists in our 
diagnostic system (DSM), we were unable to identify these symptoms as one syndrome called asthenia.  
To answer that question, future research is needed, and the most important need is to have more 
experience on long-duration missions (6 months to 2 years). To determine whether astronauts or 
cosmonauts develop asthenia in space, the authors suggest that the following steps would be necessary:  
1. The United States (including NASA) would determine the duration of the symptoms of asthenia 
(as defined by others) in astronauts, and then try to identify the context within which these 
symptoms occur—the frequency of symptom development and the conditions that seem to be 
associated with the development of symptoms in individuals.  
2. Research would have to be conducted to produce a clear definition of what asthenia is, what its 
symptoms are, and what causes it. Once NASA has collected data on the epidemiology of the 
symptoms, how they present in individual astronauts, and under what conditions they seem to 
occur, then NASA researchers would begin to explore the etiology of the syndrome.  
3. An effort to diagnose and prevent asthenia and other psychological symptoms during space 
missions would need to be done through international cooperation; thus a transcultural diagnosis 
would be necessary. As professionals in the field of space psychology and psychiatry, we have to 
remember that culture does influence the manifestation of disorders. Therefore, one route to 
follow would be to see what asthenia symptoms look like and how individuals think about the 
symptoms and experience of the disorder. We would have to explore those symptoms in the U.S. 
cultural context first, and then the syndrome as evidenced in U.S. astronauts could be compared 
to the way it develops and presents itself in Russian cosmonauts and any other travelers in space.  
4. This research would need to include astronaut (U.S., Canadian, Japanese, and European) and 
cosmonaut participants who would be in space for long periods, to see what kind of psychological 
symptoms would develop and investigate the reasons for their development (for example, 
microgravity, increased exposure to radiation, and changes in levels of carbon dioxide).  
5. This research would also need to address whether asthenia or neurasthenia in space happens as a 
consequence of environmental factors such as exposure to radiation, interior lighting, isolation, 
microgravity, or changes in levels of carbon dioxide, or if it is due to individual differences or 
other psychological factors.  
At this time, the existence of asthenia in long-duration space missions has still not been proven. As we 
saw in our comparative analysis, however, an alternative approach to determine psychological factors in 
long-duration missions would be to focus on conditions that involve affect, cognition, and behavior. If the 
focus is put on identifying factors related to these psychological functions, this specificity will help us to 
detect symptoms early, and this could prevent such conditions as asthenia and thus affect the mental and 
physiological performance of the crew. Other ways to prevent asthenia would include more focused 
attention on the six most frequent symptoms identified in the analysis described above (difficult 
concentration, fatigue [non-organic related], sleep disturbance, decrease in occupational performance, 
somatic disease, and irritability) and use of scientific tools and assessments to identify changes in those 
areas.  
In sum, we believe that asthenia is a good example of a syndrome or condition that can lead to more 
research in the new field of space psychology. Future research on space psychological factors that might 
arise in long-duration space flight missions (1 year or longer) is needed as well as international 
collaboration to determine a transcultural diagnosis of asthenia or other psychological pathologies.  
 ―I think the human race has no future if it doesn't go into space.‖  
—Stephen Hawking (2007)  
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